查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1605911

醫藥品有效成分市場，規模，佔有率，趨勢，產業分析報告:各產品類型，不同形態，各廠商類型，各用途，各地區 - 市場預測 2025年～2034年

Active Pharmaceutical Ingredient Market Size, Share, Trends, Industry Analysis Report: By Product Type, Form, Manufacturer Type, Application, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到 2034 年，活性藥物成分 (API) 市場預計將達到 4,369 億美元。該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

全球對仿製藥和非處方藥的需求不斷增長，推動了活性藥物成分 (API) 市場的成長。例如，美國非處方藥零售額從2000年的147億美元增加到2023年的434億美元。這意味著從 2000 年到 2023 年顯著增加了 330 億美元。此外，2018年至2023年非處方藥銷售額成長了3.6%。

公共和私人資本的投資和融資的增加預計將推動活性藥物成分市場的成長。藥物配方、生產的進步以及藥物發現時間的縮短正在吸引尋求更高投資回報的投資者。例如，2024年8月，領先的注射藥物公司Vivint Pharma宣布計劃在海德拉巴基因谷建造先進的注射生產設施。該公司將投資 4,800 萬美元建造新工廠，這將創造 1,000 個就業崗位，並鞏固 Telangana 作為全球生命科學中心的地位。這項消息是在特倫甘納邦首席部長 Shri A. Revanth Reddy 與美國工商部長 Shri D. Sridhar Babu 舉行的高級別會議上宣布的。 Vivint Pharma 已在 Genome Valley 設立了耗資 850 萬美元的研發中心，並正在擴大在印度的業務。為了幫助拓展國際市場，該公司在基因谷收購了 5.5 英畝的土地，該谷以其世界一流的基礎設施和創新生態系統而聞名。

製藥公司是活性藥物成分的主要消費者和製造商。投資的增加和政府的激勵措施促使具有創新理念的新進入者增加，對老牌製藥巨頭構成了挑戰。

活性藥物成分 (API) 市場報告重點

按格式分析表明，水劑細分市場的複合年增長率很高，預計市場將出現顯著增長。這種增長歸因於水性藥物在各種形式的藥品中的廣泛使用。

到 2024 年，北美將主導 API 市場。

由於中國對生物技術創新的監管支持和資金支持，中國的活性藥物成分 (API) 市場預計將大幅成長。

主要市場企業有Pfizer; Teva Pharmaceuticals Industries Ltd.; GSK PLC; Sanofi; Eli Lilly and Company; Merck KGaA; AbbVie Inc.; F-Hoffman La Roche Ltd; AstraZeneca; Dr. Reddy's Laboratory Ltd.; BASF Corporation; Sun Pharmaceutical Industries Ltd.; Curia Global Inc.; and 南京市 Jianyou Biochemical Pharmaceutical 是Co., Ltd.。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球醫藥品有效成分(API)市場洞察

  • 市場概述
  • 醫藥品有效成分(API)市場動態
    • 促進因素和機會
      • 醫藥領域投資加大，市場規模不斷擴大
      • 管道藥物的增加推動市場成長
    • 抑制因素和挑戰
      • 缺乏熟練勞動力
  • PESTEL分析
  • 醫藥品有效成分(API)市場趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球醫藥品有效成分(API)市場:各產品類型

  • 主要調查結果
  • 簡介
  • 單株抗體
  • 免疫球蛋白
  • 細胞激素
  • 胰島素
  • [月太]激素
  • 血液因子
  • [月太]抗生素
  • 疫苗
  • 低分子抗生素
  • 高功效醫藥品有效成分(HPAPI)
  • 其他

第6章 全球醫藥品有效成分(API)市場:不同形態

  • 主要調查結果
  • 簡介
  • 水性液體
  • 非水性液體
  • 乾燥粉末

第7章 全球醫藥品有效成分(API)市場:各廠商類型

  • 主要調查結果
  • 簡介
  • 適合自家公司
  • 適合外販

第8章 全球醫藥品有效成分(API)市場:各用途

  • 主要調查結果
  • 簡介
  • 心臟病
  • 腫瘤學
  • 中樞神經系統和神經學
  • 整形外科
  • 內分泌學
  • 呼吸系統醫療設備
  • 消化器官內科
  • 腎臟學
  • 眼科
  • 其他

第9章 全球醫藥品有效成分(API)市場:各地區

  • 主要調查結果
  • 簡介
    • 醫藥品有效成分(API)市場評估:地區，2020～2034年
  • 北美
    • 北美:各產品類型，2020～2034年
    • 北美:不同形態，2020～2034年
    • 北美:各廠商類型，2020～2034年
    • 北美:各應用領域，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各產品類型，2020～2034年
    • 歐洲:不同形態，2020～2034年
    • 歐洲:各廠商類型，2020～2034年
    • 歐洲:各應用領域，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各產品類型，2020～2034年
    • 亞太地區:不同形態，2020～2034年
    • 亞太地區:各廠商類型，2020～2034年
    • 亞太地區:各應用領域，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各產品類型，2020～2034年
    • 中東·非洲:不同形態，2020～2034年
    • 中東·非洲:各廠商類型，2020～2034年
    • 中東·非洲:各應用領域，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:各產品類型，2020～2034年
    • 南美:不同形態，2020～2034年
    • 南美:各廠商類型，2020～2034年
    • 南美:各應用領域，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第11章 企業簡介

  • Pfizer
  • Teva Pharmaceuticals Ltd
  • GSK PLC
  • Sanofi
  • Eli Lilly and Company
  • Merck KGaA
  • AbbVie Inc.
  • F-Hoffman La Roche Ltd
  • AstraZeneca
  • Dr. Reddy's Laboratory
  • BASF Corporation
  • Sun Pharmaceuticals Industries Ltd.
  • Curia Global Inc.
  • Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
Product Code: PM1703

The active pharmaceutical ingredient market size is expected to reach USD 436.90 billion by 2034, according to a new study by Polaris Market Research. The report "Active Pharmaceutical Ingredient (API) Market Size, Share, Trends, Industry Analysis Report: By Product Type, Form (Aqueous, Non-Aqueous Liquid, and Dry Powder), Manufacturer Type, Application, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The active pharmaceutical ingredient (API) market growth is driven by increasing demand for generic drugs and over-the-counter drugs worldwide. For instance, the retail sales of over-the-counter drugs in the US have risen to 43.4 billion USD in 2023 from 14.7 billion dollar USD in 2000. This represents a significant increase of 33 billion dollar USD from 2000 to 2023. Additionally, the sales revenue of OTC drugs from 2018 to 2023 has grown by 3.6%

Increasing investments and funding from public and private capitalists are anticipated to fuel active pharmaceutical market growth. Advancements in drug formulations, production, and short drug discovery timelines have been attracting investors seeking better returns on their investments. For instance, in August 2024, Vivint Pharma, a leading injectables pharmaceutical company, announced plans to build an advanced injectables manufacturing facility in Genome Valley, Hyderabad. The company will invest $48 million in the new facility, which is expected to create 1,000 jobs and strengthen Telangana's position as a global life sciences hub. The announcement was made during a high-level meeting with Telangana's Chief Minister, Shri A. Revanth Reddy, and Minister for Industries and Commerce, Sri D. Sridhar Babu, in the US. Vivint Pharma, which already has a $8.5 million R&D center in Genome Valley, is expanding its footprint in India. The company has acquired 5.5 acres in Genome Valley, known for its world-class infrastructure and innovation ecosystem, to support its entry into international markets.

Pharmaceutical companies are major consumers and manufacturers of active pharmaceutical ingredients. Increasing investment and government incentives have led to a rise in the number of new players with innovative ideas, challenging the existing pharmaceutical giants.

Active Pharmaceutical Ingredient (API) Market Report Highlights

By form analysis, the aqueous segment is anticipated to experience substantial growth with a significant CAGR in the market. This growth is attributed to the wide range of applications of the aqueous active pharmaceutical ingredient in different forms of drugs.

In 2024, North America dominated the API market due to the established presence of several companies within the region.

The active pharmaceutical ingredient (API) market in China is projected for substantial growth due to the regulatory support and funding for biotech innovations within the country.

The key market players are Pfizer; Teva Pharmaceuticals Industries Ltd.; GSK PLC; Sanofi; Eli Lilly and Company; Merck KGaA; AbbVie Inc.; F-Hoffman La Roche Ltd; AstraZeneca; Dr. Reddy's Laboratory Ltd.; BASF Corporation; Sun Pharmaceutical Industries Ltd.; Curia Global Inc.; and Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.

Polaris Market Research has segmented the active pharmaceutical ingredient market report based on product type, form, manufacturer type, application, and region:

By Product Type Outlook (Revenue - USD Billion, 2020-2034)

  • mAb
  • Immunoglobulin
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Blood Factors
  • Peptide Antibiotics
  • Vaccines
  • Small Molecule Antibiotics
  • Highly Potent Active Pharmaceutical Ingredient (HPAPI)
  • Others

By Form Outlook (Revenue - USD Billion, 2020-2034)

  • Aqueous
  • Non-Aqueous Liquid
  • Dry Powder

By Manufacturer Type Outlook (Revenue - USD Billion, 2020-2034)

  • Captive
  • Merchant

By Application Outlook (Revenue - USD Billion, 2020-2034)

  • Cardiology
  • Oncology
  • CNS & Neurology
  • Orthopedic
  • Endocrinology
  • Pulmonology
  • Gastroenterology
  • Nephrology
  • Ophthalmology
  • Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of the Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Active Pharmaceutical Ingredient (API) Market Insights

  • 4.1. Active Pharmaceutical Ingredient (API) Market - Market Snapshot
  • 4.2. Active Pharmaceutical Ingredient (API) Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Investment in Pharmaceutical Sector is Driving the Market Size
      • 4.2.1.2. Increasing Number of Pipeline Drugs Are Driving the Market Growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of Skilled Workforce
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Active Pharmaceutical Ingredient (API) Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Active Pharmaceutical Ingredient (API) Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • 5.3. mAb
    • 5.3.1. Global Active Pharmaceutical Ingredient (API) Market, by mAb, by Region, 2020-2034 (USD Billion)
  • 5.4. Immunoglobulin
    • 5.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Immunoglobulin, by Region, 2020-2034 (USD Billion)
  • 5.5. Cytokines
    • 5.5.1. Global Active Pharmaceutical Ingredient (API) Market, by Cytokines, by Region, 2020-2034 (USD Billion)
  • 5.6. Insulin
    • 5.6.1. Global Active Pharmaceutical Ingredient (API) Market, by Insulin, by Region, 2020-2034 (USD Billion)
  • 5.7. Peptide Hormones
    • 5.7.1. Global Active Pharmaceutical Ingredient (API) Market, by Peptide Hormones, by Region, 2020-2034 (USD Billion)
  • 5.8. Blood Factors
    • 5.8.1. Global Active Pharmaceutical Ingredient (API) Market, by Blood Factors, by Region, 2020-2034 (USD Billion)
  • 5.9. Peptide Antibiotics
    • 5.9.1. Global Active Pharmaceutical Ingredient (API) Market, by Peptide Antibiotics, by Region, 2020-2034 (USD Billion)
  • 5.10. Vaccines
    • 5.10.1. Global Active Pharmaceutical Ingredient (API) Market, by Vaccines, by Region, 2020-2034 (USD Billion)
  • 5.11. Small Molecule Antibiotics
    • 5.11.1. Global Active Pharmaceutical Ingredient (API) Market, by Small Molecule Antibiotics, by Region, 2020-2034 (USD Billion)
  • 5.12. Highly Potent Active Pharmaceutical Ingredient (HPAPI)
    • 5.12.1. Global Active Pharmaceutical Ingredient (API) Market, by Highly Potent Active Pharmaceutical Ingredient (HPAPI), by Region, 2020-2034 (USD Billion)
  • 5.13. Others
    • 5.13.1. Global Active Pharmaceutical Ingredient (API) Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Active Pharmaceutical Ingredient (API) Market, by Form

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • 6.3. Aqueous
    • 6.3.1. Global Active Pharmaceutical Ingredient (API) Market, by Aqueous, by Region, 2020-2034 (USD Billion)
  • 6.4. Non-Aqueous Liquid
    • 6.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Non-Aqueous Liquid, by Region, 2020-2034 (USD Billion)
  • 6.5. Dry Powder
    • 6.5.1. Global Active Pharmaceutical Ingredient (API) Market, by Dry Powder, by Region, 2020-2034 (USD Billion)

7. Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • 7.3. Captive
    • 7.3.1. Global Active Pharmaceutical Ingredient (API) Market, by Captive, by Region, 2020-2034 (USD Billion)
  • 7.4. Merchant
    • 7.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Merchant, by Region, 2020-2034 (USD Billion)

8. Global Active Pharmaceutical Ingredient (API) Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 8.3. Cardiology
    • 8.3.1. Global Active Pharmaceutical Ingredient (API) Market, by Cardiology, by Region, 2020-2034 (USD Billion)
  • 8.4. Oncology
    • 8.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 8.5. CNS & Neurology
    • 8.5.1. Global Active Pharmaceutical Ingredient (API) Market, by CNS & Neurology, by Region, 2020-2034 (USD Billion)
  • 8.6. Orthopedic
    • 8.6.1. Global Active Pharmaceutical Ingredient (API) Market, by Orthopedic, by Region, 2020-2034 (USD Billion)
  • 8.7. Endocrinology
    • 8.7.1. Global Active Pharmaceutical Ingredient (API) Market, by Endocrinology, by Region, 2020-2034 (USD Billion)
  • 8.8. Pulmonology
    • 8.8.1. Global Active Pharmaceutical Ingredient (API) Market, by Pulmonology, by Region, 2020-2034 (USD Billion)
  • 8.9. Gastroenterology
    • 8.9.1. Global Active Pharmaceutical Ingredient (API) Market, by Gastroenterology, by Region, 2020-2034 (USD Billion)
  • 8.10. Nephrology
    • 8.10.1. Global Active Pharmaceutical Ingredient (API) Market, by Nephrology, by Region, 2020-2034 (USD Billion)
  • 8.11. Ophthalmology
    • 8.11.1. Global Active Pharmaceutical Ingredient (API) Market, by Nephrology, by Region, 2020-2034 (USD Billion)
  • 8.12. Others
    • 8.12.1. Global Active Pharmaceutical Ingredient (API) Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Active Pharmaceutical Ingredient (API) Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Active Pharmaceutical Ingredient (API) Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Active Pharmaceutical Ingredient (API) Market - North America
    • 9.3.1. North America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.3.2. North America: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.3.3. North America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.3.4. North America: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.3.5. Active Pharmaceutical Ingredient (API) Market - U.S.
      • 9.3.5.1. U.S.: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.3.5.2. U.S.: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.3.5.3. U.S.: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.3.5.4. U.S.: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.3.6. Active Pharmaceutical Ingredient (API) Market - Canada
      • 9.3.6.1. Canada: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.4. Active Pharmaceutical Ingredient (API) Market - Europe
    • 9.4.1. Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.4.5. Active Pharmaceutical Ingredient (API) Market - UK
      • 9.4.5.1. UK: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.4.6. Active Pharmaceutical Ingredient (API) Market - France
      • 9.4.6.1. France: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.4.7. Active Pharmaceutical Ingredient (API) Market - Germany
      • 9.4.7.1. Germany: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.4.8. Active Pharmaceutical Ingredient (API) Market - Italy
      • 9.4.8.1. Italy: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.4.9. Active Pharmaceutical Ingredient (API) Market - Spain
      • 9.4.9.1. Spain: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.4.10. Active Pharmaceutical Ingredient (API) Market - Netherlands
      • 9.4.10.1. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.4.11. Active Pharmaceutical Ingredient (API) Market - Russia
      • 9.4.11.1. Russia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.4.12. Active Pharmaceutical Ingredient (API) Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.5. Active Pharmaceutical Ingredient (API) Market - Asia Pacific
    • 9.5.1. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.5.5. Active Pharmaceutical Ingredient (API) Market - China
      • 9.5.5.1. China: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.5.6. Active Pharmaceutical Ingredient (API) Market - India
      • 9.5.6.1. India: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.5.7. Active Pharmaceutical Ingredient (API) Market - Malaysia
      • 9.5.7.1. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.5.8. Active Pharmaceutical Ingredient (API) Market - Japan
      • 9.5.8.1. Japan: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.5.9. Active Pharmaceutical Ingredient (API) Market - Indonesia
      • 9.5.9.1. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.5.10. Active Pharmaceutical Ingredient (API) Market - South Korea
      • 9.5.10.1. South Korea: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.5.11. Active Pharmaceutical Ingredient (API) Market - Australia
      • 9.5.11.1. Australia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.5.12. Active Pharmaceutical Ingredient (API) Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.6. Active Pharmaceutical Ingredient (API) Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.6.5. Active Pharmaceutical Ingredient (API) Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.6.6. Active Pharmaceutical Ingredient (API) Market - UAE
      • 9.6.6.1. UAE: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.6.7. Active Pharmaceutical Ingredient (API) Market - Israel
      • 9.6.7.1. Israel: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.6.8. Active Pharmaceutical Ingredient (API) Market - South Africa
      • 9.6.8.1. South Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.6.9. Active Pharmaceutical Ingredient (API) Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • 9.7. Active Pharmaceutical Ingredient (API) Market - Latin America
    • 9.7.1. Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.7.5. Active Pharmaceutical Ingredient (API) Market - Mexico
      • 9.7.5.1. Mexico: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.7.6. Active Pharmaceutical Ingredient (API) Market - Brazil
      • 9.7.6.1. Brazil: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.7.7. Active Pharmaceutical Ingredient (API) Market - Argentina
      • 9.7.7.1. Argentina: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
    • 9.7.8. Active Pharmaceutical Ingredient (API) Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Pfizer
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Teva Pharmaceuticals Ltd
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. GSK PLC
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Sanofi
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Eli Lilly and Company
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Merck KGaA
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. AbbVie Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. F-Hoffman La Roche Ltd
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. AstraZeneca
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Dr. Reddy's Laboratory
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. BASF Corporation
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Sun Pharmaceuticals Industries Ltd.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Curia Global Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development

List of Tables:

  • Table 1 Global Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 2 Global Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 3 Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 4 Global Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 5 North America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 6 North America: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 7 North America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 8 North America: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 10 U.S.: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 11 U.S.: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 12 U.S.: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 13 Canada: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 14 Canada: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 15 Canada: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 16 Canada: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 17 Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 18 Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 19 Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 20 Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 21 UK: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 22 UK: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 23 UK: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 24 UK: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 25 France: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 26 France: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 27 France: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 28 France: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 29 Germany: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 30 Germany: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 31 Germany: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 32 Germany: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Italy: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 34 Italy: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 35 Italy: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 36 Italy: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 37 Spain: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 38 Spain: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 39 Spain: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 40 Spain: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 45 Russia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 46 Russia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 47 Russia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 48 Russia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 57 China: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 58 China: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 59 China: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 60 China: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 61 India: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 62 India: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 63 India: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 64 India: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Japan: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 70 Japan: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 71 Japan: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 72 Japan: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 77 South Korea: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 78 South Korea: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 79 South Korea: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 80 South Korea: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 81 Australia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 82 Australia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 83 Australia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 84 Australia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 97 UAE: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 98 UAE: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 99 UAE: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 100 UAE: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 101 Israel: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 102 Israel: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 103 Israel: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 104 Israel: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 105 South Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 106 South Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 107 South Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 108 South Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 113 Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 114 Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 115 Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 116 Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 117 Mexico: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 118 Mexico: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 119 Mexico: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 120 Mexico: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 121 Brazil: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 122 Brazil: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 123 Brazil: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 124 Brazil: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 125 Argentina: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 126 Argentina: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 127 Argentina: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 128 Argentina: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
  • List of Figures:
  • Figure 1. Global Active Pharmaceutical Ingredient (API) Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Type
  • Figure 7. Global Active Pharmaceutical Ingredient (API) Market, by Product Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Form
  • Figure 9. Global Active Pharmaceutical Ingredient (API) Market, by Form, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Manufacturer Type
  • Figure 11. Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Application
  • Figure 13. Global Active Pharmaceutical Ingredient (API) Market, by Application, 2024 & 2034 (USD Billion)